Ambea AB (publ)
STO:AMBEA
Ambea AB (publ)
Ambea AB engages in the provision of elderly care, disability care, and staffing. The company is headquartered in Solna, Stockholm and currently employs 14,292 full-time employees. The company went IPO on 2017-03-31. The Ambea group offers accommodation, support, training and staffing within health and social care. The Group has over 450 units throughout Sweden and in Norway. The Swedish operations comprise the brands Vardaga, Lara and Bemanning. Among other brands, there are Rent a Doctor, Rent a Nurse, Rent a Socionom and Careteam, as well as BoA Mellanvard. The Norwegian operations comprise support and residential care in disabilities and psychiatry through the companies Heimta and Vitale. The Company’s main shareholders are ACTR Holding Ab and Actor General Partner SARL Sweden SCA. The company operates Malrettet Intervensjon AS, Elevhalsan, Stod och Resurs AB and Tiltaksgruppa fokus as subsidiaries.
Ambea AB engages in the provision of elderly care, disability care, and staffing. The company is headquartered in Solna, Stockholm and currently employs 14,292 full-time employees. The company went IPO on 2017-03-31. The Ambea group offers accommodation, support, training and staffing within health and social care. The Group has over 450 units throughout Sweden and in Norway. The Swedish operations comprise the brands Vardaga, Lara and Bemanning. Among other brands, there are Rent a Doctor, Rent a Nurse, Rent a Socionom and Careteam, as well as BoA Mellanvard. The Norwegian operations comprise support and residential care in disabilities and psychiatry through the companies Heimta and Vitale. The Company’s main shareholders are ACTR Holding Ab and Actor General Partner SARL Sweden SCA. The company operates Malrettet Intervensjon AS, Elevhalsan, Stod och Resurs AB and Tiltaksgruppa fokus as subsidiaries.
Strong Quarter: Ambea reported another strong quarter, with net sales up 16%, driven by both acquisitions and organic growth.
Profitability: Adjusted EBITA increased by 19% and reached a margin of 13.9%, while rolling 12-month adjusted EBITA margin sits at 9.9%, above the company’s target.
Growth Drivers: Growth was fueled by the acquisition of Validia, strong performance in Nytida, Vardaga, and Altiden, and an expanding pipeline of new care facilities.
Cash Flow: Operating cash flow increased by 30% to SEK 686 million in the quarter and cash conversion remains above 91%.
M&A Activity: Acquired annual net sales in 2025 surpassed SEK 1.6 billion, with continued focus on strategic bolt-on acquisitions, especially in Finland.
Shareholder Returns: Ambea continued its share buyback program (2 million shares) and distributed SEK 185 million in dividends.
Outlook: Management expects continued growth through both organic expansion and further acquisitions, with a strong pipeline and positive market prospects.
